Whole genome sequencing identified biomarker of response to PD1 blockade in Natural-killer/T-cell lymphoma

ABSTRACT: WGS data of 13 and TCS data of 8 NKTCL patients. Significant association of PD-L1 rearrangements with objective response to anti-PD1 (pembrolizumab).

PROVIDER: EGAS00001002420 | EGA |

REPOSITORIES: EGA